799 related articles for article (PubMed ID: 26491974)
1. Recent advances in the management of AL Amyloidosis.
Kastritis E; Dimopoulos MA
Br J Haematol; 2016 Jan; 172(2):170-86. PubMed ID: 26491974
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in understanding and treating immunoglobulin light chain amyloidosis.
Badar T; D'Souza A; Hari P
F1000Res; 2018; 7():. PubMed ID: 30228867
[TBL] [Abstract][Full Text] [Related]
3. Systemic light-chain amyloidosis: advances in diagnosis, prognosis, and therapy.
Cohen AD; Comenzo RL
Hematology Am Soc Hematol Educ Program; 2010; 2010():287-94. PubMed ID: 21239808
[TBL] [Abstract][Full Text] [Related]
4. New insights and modern treatment of AL amyloidosis.
Chaulagain CP; Comenzo RL
Curr Hematol Malig Rep; 2013 Dec; 8(4):291-8. PubMed ID: 24026941
[TBL] [Abstract][Full Text] [Related]
5. New and developing therapies for AL amyloidosis.
Zumbo G; Sadeghi-Alavijeh O; Hawkins PN; Fontana M
Expert Opin Pharmacother; 2017 Feb; 18(2):139-149. PubMed ID: 28002971
[TBL] [Abstract][Full Text] [Related]
6. Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosis.
Comenzo RL
Contrib Nephrol; 2007; 153():195-210. PubMed ID: 17075231
[TBL] [Abstract][Full Text] [Related]
7. Managing systemic light-chain amyloidosis.
Comenzo RL
J Natl Compr Canc Netw; 2007 Feb; 5(2):179-87. PubMed ID: 17335687
[TBL] [Abstract][Full Text] [Related]
8. Light chain (AL) amyloidosis: update on diagnosis and management.
Rosenzweig M; Landau H
J Hematol Oncol; 2011 Nov; 4():47. PubMed ID: 22100031
[TBL] [Abstract][Full Text] [Related]
9. Future directions in the clinical management of amyloid light-chain amyloidosis.
Haider S; Ahmad N; Anaissie E; Driscoll JJ
Leuk Lymphoma; 2014 Oct; 55(10):2241-51. PubMed ID: 24359238
[TBL] [Abstract][Full Text] [Related]
10. Treatment of primary systemic amyloidosis (AL): role of intensive and standard therapy.
Sher T; Hayman SR; Gertz MA
Clin Adv Hematol Oncol; 2012 Oct; 10(10):644-51. PubMed ID: 23187770
[TBL] [Abstract][Full Text] [Related]
11. [Immunoglobulin light chain amyloidosis: recent molecular, clinical and therapeutic approach].
Thierry A; Bridoux F; Goodman H; Belmouaz S; Abou Ayache R; Desport E; Jaccard A; Touchard G
Nephrologie; 2004; 25(4):111-8. PubMed ID: 15291138
[TBL] [Abstract][Full Text] [Related]
12. New Light Chain Amyloid Response Criteria Help Risk Stratification of Patients by Day 100 after Autologous Hematopoietic Cell Transplantation.
D'Souza A; Huang J; Hari P
Biol Blood Marrow Transplant; 2016 Apr; 22(4):768-770. PubMed ID: 26743343
[TBL] [Abstract][Full Text] [Related]
13. New developments in diagnosis, risk assessment and management in systemic amyloidosis.
Vaxman I; Dispenzieri A; Muchtar E; Gertz M
Blood Rev; 2020 Mar; 40():100636. PubMed ID: 31706583
[TBL] [Abstract][Full Text] [Related]
14. [Amyloid light chain amyloidosis].
Suzuki K; Shimizu T
Brain Nerve; 2014 Jul; 66(7):795-809. PubMed ID: 24998824
[TBL] [Abstract][Full Text] [Related]
15. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
16. How we treat systemic light-chain amyloidosis.
Chaulagain CP; Comenzo RL
Clin Adv Hematol Oncol; 2015 May; 13(5):315-24. PubMed ID: 26352777
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in the Diagnosis, Risk Stratification, and Management of Systemic Light-Chain Amyloidosis.
Vaxman I; Gertz M
Acta Haematol; 2019; 141(2):93-106. PubMed ID: 30650422
[TBL] [Abstract][Full Text] [Related]
18. Review: immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability.
Bellotti V; Mangione P; Merlini G
J Struct Biol; 2000 Jun; 130(2-3):280-9. PubMed ID: 10940232
[TBL] [Abstract][Full Text] [Related]
19. Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation.
Hwa YL; Kumar SK; Gertz MA; Lacy MQ; Buadi FK; Kourelis TV; Gonsalves WI; Rajkumar SV; Go RS; Leung N; Kapoor P; Dingli D; Kyle RA; Russell S; Lust JA; Hayman SR; Lin Y; Zeldenrust S; Dispenzieri A
Am J Hematol; 2016 Oct; 91(10):984-8. PubMed ID: 27341539
[TBL] [Abstract][Full Text] [Related]
20. Ten-year follow-up after autologous stem cell transplantation of a patient with immunoglobulin light-chain (AL) amyloidosis with deposits in the heart, liver and gastrointestinal tract.
Mejhert M; Hast R; Sandstedt B; Janczewska I
BMJ Case Rep; 2011 Aug; 2011():. PubMed ID: 22688930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
